Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has shared an announcement.
Shandong Xinhua Pharmaceutical Company Limited has announced that it has received the Drug Registration Certificate for its Icosapent Ethyl soft capsules from the National Medical Products Administration. This certification allows the company to proceed with the production and sale of the drug, which is expected to enhance its market presence and operational capabilities in the pharmaceutical sector.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a pharmaceutical company based in China, focusing on the production and sale of prescription drugs. The company operates within the pharmaceutical industry and is involved in the development and marketing of chemical drugs, with a particular emphasis on domestic production.
Average Trading Volume: 4,260,784
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.58B
Find detailed analytics on 0719 stock on TipRanks’ Stock Analysis page.